Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.69B |
| 2 |
Qualcomm
QCOM
|
+$1.73B |
| 3 |
Broadcom
AVGO
|
+$1.21B |
| 4 |
Altria Group
MO
|
+$1.21B |
| 5 |
Abbott
ABT
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$2.08B |
| 2 |
Amazon
AMZN
|
+$2.06B |
| 3 |
Netflix
NFLX
|
+$1.28B |
| 4 |
Verizon
VZ
|
+$1.06B |
| 5 |
GE Aerospace
GE
|
+$972M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.35% |
| 2 | Communication Services | 14.02% |
| 3 | Technology | 13.86% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Financials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$435B
| $18B | 4.9% |
193,768,855
+686,114
| +0.4% | +$67M |
|
|
2
Netflix
NFLX
$309B
| $14.7B | 4.02% |
376,279,870
-37,657,070
| -9% | -$1.28B |
|
|
3
Amazon
AMZN
$2.96T
| $11.6B | 3.17% |
136,690,420
-25,934,740
| -16% | -$2.06B |
|
4
Microsoft
MSFT
$3.71T
| $10.2B | 2.78% |
103,326,554
+2,713,274
| +3% | +$263M |
|
5
Amgen
AMGN
$222B
| $8.48B | 2.32% |
45,938,476
-1,096,159
| -2% | -$194M |
|
|
6
Abbott
ABT
$187B
| $8B | 2.18% |
131,099,788
+18,000,566
| +16% | +$1.09B |
|
7
Alphabet (Google) Class C
GOOG
$4.32T
| $7.2B | 1.97% |
128,990,900
+6,277,660
| +5% | +$339M |
|
|
8
Meta Platforms (Facebook)
META
$1.51T
| $6.83B | 1.87% |
35,167,092
+20,406,462
| +138% | +$3.69B |
|
9
EOG Resources
EOG
$70.7B
| $6.39B | 1.75% |
51,360,361
+7,581,875
| +17% | +$881M |
|
|
10
Verizon
VZ
$196B
| $6.07B | 1.66% |
120,565,587
-21,846,302
| -15% | -$1.06B |
|
11
UnitedHealth
UNH
$370B
| $6.01B | 1.64% |
24,509,248
+1,998,446
| +9% | +$480M |
|
|
12
Alphabet (Google) Class A
GOOGL
$4.33T
| $5.83B | 1.59% |
103,322,000
+2,113,280
| +2% | +$115M |
|
13
Intel
INTC
$513B
| $5.69B | 1.56% |
114,532,541
-2,014,015
| -2% | -$107M |
|
|
14
Broadcom
AVGO
$2.04T
| $5.36B | 1.46% |
220,863,300
+49,205,980
| +29% | +$1.21B |
|
15
CSX Corp
CSX
$93.1B
| $4.7B | 1.28% |
221,005,449
-46,624,368
| -17% | -$960M |
|
16
ExxonMobil
XOM
$634B
| $4.47B | 1.22% |
54,070,428
+13,483,489
| +33% | +$1.07B |
|
|
17
Altria Group
MO
$114B
| $4.46B | 1.22% |
78,510,532
+20,894,458
| +36% | +$1.21B |
|
18
General Dynamics
GD
$106B
| $4.4B | 1.2% |
23,616,787
+3,316,735
| +16% | +$679M |
|
19
Wells Fargo
WFC
$264B
| $4.33B | 1.18% |
78,101,262
+209,711
| +0.3% | +$11.2M |
|
20
Nike
NKE
$61.9B
| $4.3B | 1.18% |
53,994,840
+572,919
| +1% | +$40.4M |
|
21
Accenture
ACN
$108B
| $4.27B | 1.17% |
26,102,682
-1,239,905
| -5% | -$193M |
|
22
Gilead Sciences
GILD
$165B
| $4.04B | 1.1% |
57,036,667
+14,093,328
| +33% | +$995M |
|
23
Stryker
SYK
$130B
| $3.98B | 1.09% |
23,548,587
-5,777,611
| -20% | -$972M |
|
24
Home Depot
HD
$355B
| $3.86B | 1.06% |
19,807,984
-662,781
| -3% | -$124M |
|
25
Thermo Fisher Scientific
TMO
$220B
| $3.86B | 1.05% |
18,614,856
-216,590
| -1% | -$46M |
|
Similar funds
Capital Research Global Investors's Q2 2018 Portfolio in Review
As of Q2 2018, Capital Research Global Investors held 476 positions worth $366B, up 4.2% from $351B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q2 2018 filing shows 33 new, 153 increased, 172 reduced and 36 closed positions. Its largest new stake was Diamondback Energy: 7,748,206 shares worth $1.02B. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $2.08B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Communication Services and Technology.
- Capital Research Global Investors's largest Q2 2018 buy was Diamondback Energy: 7,748,206 shares worth $1.02B.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q2 2018, an estimated $3.69B increase.
- Capital Research Global Investors's biggest Q2 2018 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $2.08B.
- Capital Research Global Investors fully exited Goldman Sachs in Q2 2018, selling an estimated $515M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $366B portfolio in Q2 2018.
- Capital Research Global Investors opened 33 new positions and closed 36 in Q2 2018.
- Capital Research Global Investors's portfolio value rose 4.2% quarter-over-quarter to $366B.
Based on Capital Research Global Investors's 13F filing for Q2 2018, filed 14 Aug 2018.